Drug Type Small molecule drug |
Synonyms 2-PAM-chloride, Pralidoxime (INN), Pralidoxime chloride (USP) + [3] |
Target |
Mechanism AChE activators(Acetylcholinesterase activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date US (11 Mar 1964), |
Regulation- |
Molecular FormulaC7H9ClN2O |
InChIKeyHIGSLXSBYYMVKI-UHFFFAOYSA-N |
CAS Registry51-15-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00469 | Pralidoxime Chloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Muscle Weakness | US | 11 Mar 1964 | |
Myasthenia Gravis | US | 11 Mar 1964 | |
Organophosphate Poisoning | US | 11 Mar 1964 | |
Respiratory Insufficiency | US | 11 Mar 1964 |
Not Applicable | - | (natasbiyjt) = qzzudiliem lkxewwvqqw (fmluzqcrji ) View more | Negative | 30 Jun 2009 | |||
Saline placebo | (natasbiyjt) = oxlabjmrvc lkxewwvqqw (fmluzqcrji ) View more | ||||||
Not Applicable | 200 | (ccuizxhfao) = cerljglrlw edhniipvtr (ybacaebskp ) | Positive | 16 Dec 2006 | |||
Repeated bolus injection | (ccuizxhfao) = jldwbyclzm edhniipvtr (ybacaebskp ) |